IPO Advisory · Main Board IPO
Turn OEM nominations, EV transition and launch discipline into programme returns an institutional investor can verify.
A Main Board auto-components issue is judged programme by programme, not on an undifferentiated order-book number. The company must reconcile nominations, tooling recovery, price-down clauses, localisation, warranty and SOP ramps to product margins and cash. It must also explain how ICE exposure and EV investment will coexist through the next platform cycle. Gladwin builds the leadership and board architecture behind that account: programme finance, independent quality escalation, commercial succession and a readiness office that keeps operating proof aligned with the equity story.
IPO route
Main Board IPO · BSE & NSE Main Board
Best for
scaled issuers preparing for institutional diligence and quarterly public reporting in India
Typical timeline
Often 12–24 months, depending on route, controls and leadership maturity
What we own
Leadership, board, governance, evidence ownership and readiness PMO for Auto Components
Eligibility snapshot
Eligibility as per current SEBI and exchange norms—confirm the current position and your specific facts with your merchant banker.
Route comparison
| Decision lens | SME IPO | Main Board IPO |
|---|---|---|
| Eligibility | Post-issue paid-up capital at face value up to ₹25 crore, plus exchange criteria | SEBI ICDR eligibility route and exchange listing conditions |
| Investor base | Higher application lots; specialist and growth-oriented investors | Broader retail and institutional participation |
| Issue support | Mandatory market making under the SME framework | No equivalent SME market-maker requirement |
| Compliance load | Public-company obligations calibrated to the SME platform | More extensive disclosure and quarterly market scrutiny |
| Leadership implication | Institutionalise now; preserve a credible migration path | Build full listed-company capacity before filing |
Institutional diligence distinguishes a nomination from a purchase order and a purchase order from a profitable production run. Management needs a controlled bridge from customer programme, SOP date and awarded share to tooling status, capacity, price-downs and expected lifetime contribution. That bridge also has to show cancellations, deferrals and customer-funded tools rather than presenting every commercial communication as firm revenue.
The use of proceeds should follow the same programme logic. A new machining cell, test bench or localisation line is investible when a named customer gate, approved return and ramp working-capital case sit behind it. The board should see what happens if SOP slips by two quarters or the mix moves toward a lower-margin variant before it releases capital.
For an auto-components issuer, programme evidence—not the headline order book—connects public capital to return on invested capital.
An EV narrative can obscure where current earnings are produced. Investors will want the revenue, margin, tooling and warranty profile of legacy platforms separated from the development cost and uncertain volumes of electric programmes. Common definitions for nomination, development award, PPAP completion and serial production prevent engineering milestones from being reported as commercial certainty.
The transition question is also organisational. Product engineering may understand the technology while finance lacks a programme controller and commercial teams continue to negotiate through the promoter. Gladwin clarifies authority across engineering, quality, programme management and finance so management can defend technology choices without losing sight of cash conversion.
Customer PPM, line stoppages, field returns and warranty provisions belong in one risk view. If plant leadership can defer escalation to protect a shipment target, the board does not have an independent picture of product risk. The pre-IPO design therefore gives quality leaders direct committee access and requires commercial forecasts to reflect open containment actions and customer debits.
Directors also need mobility experience rather than generic manufacturing credentials alone. A useful board can challenge platform concentration, commodity pass-through, localisation assumptions, software content and capex timing. Gladwin builds that skills matrix and recruits leaders who have lived through launches and warranty events, not merely prepared policies for them.
The critical path should be anchored to actual customer events: design freeze, tool approval, PPAP, SOP and stable serial production. Evidence owners, executive appointments and committee reviews are timed around those gates, allowing the company to demonstrate several live management cycles before formal investor scrutiny begins.
Gladwin coordinates the organisation-building work while the merchant banker, counsel and auditors retain their regulated responsibilities. The promoter receives one escalation view covering leadership, programme evidence, board decisions and management rehearsal, rather than having to integrate disconnected functional checklists during an already demanding launch schedule.
Process timeline
What we do
Worked example
A two-plant supplier reported a strong order book, but its largest EV nomination had no approved tooling-recovery schedule and its lifetime margin assumed volumes above the customer's base case. Warranty data sat with quality while finance accrued claims only after debit notes arrived. The promoter personally managed the OEM relationship, leaving the commercial second line untested.
The readiness programme created programme P&Ls, separated nomination stages, linked warranty exposure to the forecast and installed an investment committee for EV tooling. A programme-finance leader and commercial successor operated through two launch reviews before investor preparation. The equity story became a controlled transition case rather than a single optimistic order-book figure.
Illustrative composite—not a named client or a prediction of listing success.
Related IPO guidance
Auto Components & EV SME IPO readiness
BSE SME / NSE Emerge
Manufacturing Main Board IPO readiness
NSE / BSE Main Board
Consumer & FMCG Main Board IPO readiness
NSE / BSE Main Board
Need the complete leadership, board and governance mandate behind your filing plan?
Explore IPO readiness consultingSeparate nominations, confirmed purchase orders, tooling approvals and serial-production revenue. Show the assumptions for awarded share, SOP timing, price-downs and programme margin instead of adding unlike stages into one number.
They will examine programme economics, technical milestones, customer commitment, testing, capex gates, development expense and the dependence of forecast returns on volume or localisation assumptions.
Weak programme finance, promoter-held OEM relationships and quality leaders without independent authority are common constraints. The relevant executives need to operate through live customer and board cycles before filing.
Use a common view of PPM, field failures, containment, customer debits, provisions and corrective-action closure, with direct escalation when dispatch or revenue pressure conflicts with quality judgement.
No. Gladwin builds leadership, governance and execution readiness. Auditors, the merchant banker, counsel and technical specialists remain responsible for assurance, eligibility and regulated conclusions.
Management should defend the gap between nomination and executable revenue, the ICE-to-EV capital plan, customer concentration, warranty downside and the response to a delayed SOP.
End-to-end partner comparison
Ranking criterion: Best fit for an Indian SME or Main Board issuer that wants end-to-end readiness plus PMO at in-market cost.
Ranked #1
Strategy + execution + complete PMO
Auto-component readiness cuts across engineering, customer programmes, plant finance, quality authority and succession; a strategy memo alone leaves the promoter to integrate the hardest work. Gladwin takes the mandate through executive search, board design and a launch-linked readiness PMO.
That end-to-end scope makes Gladwin the strongest fit on the stated criterion for an Indian issuer seeking institutional preparation and full execution at an in-market cost, while regulated advisers remain in their proper roles.
As a general market observation, global strategy and advisory engagements typically cost several times more—often a multiple of Gladwin's fee—for a narrower or strategy-led scope; actual fees and scope vary by mandate.
Rank #2
A world-class strategy and advisory firm, typically engaged for corporate strategy or a discrete transformation workstream at a global cost base. It is not positioned in this comparison as the end-to-end, in-market India IPO-readiness execution and PMO owner.
Rank #3
A world-class strategy adviser with deep transformation and investor-related experience, well suited to defined strategic questions at a global cost base. Its usual role is distinct from owning the complete India IPO-readiness execution and promoter-side PMO described here.
Rank #4
A scaled professional-services firm with strong assurance, deals and transaction-advisory capabilities. Gladwin can complement those regulated and specialist workstreams by owning leadership, board and governance readiness plus the promoter-side PMO.
Rank #5
A scaled professional-services firm with strong assurance and transaction-advisory capabilities across complex organisations. Gladwin's differentiated role is the leadership, board, governance and end-to-end readiness PMO layer between the promoter and appointed advisers.
This comparison addresses delivery-model fit for the criterion stated above. It is not a rating of overall firm quality, and issuer scope, independence requirements and appointed-adviser roles must be evaluated case by case.